Elana van Brakel

Final Analysis of a Trial of M72/AS01 _E Vaccine to Prevent Tuberculosis

Dereck Tait, Mark Hatherill, Olivier Van Der Meeren et al. · New England Journal of Medicine · 2019 · 561 citations · Full text

Phase 2b Controlled Trial of M72/AS01 _E Vaccine to Prevent Tuberculosis

Olivier Van Der Meeren, Mark Hatherill, Videlis Nduba et al. · New England Journal of Medicine · 2018 · 392 citations · Full text

Early Bactericidal Activity of AZD5847 in Patients with Pulmonary Tuberculosis

Jennifer Furin, Jeannine du Bois, Elana van Brakel et al. · Antimicrobial Agents and Chemotherapy · 2016 · 26 citations · Full text

Immunogenicity, safety, and efficacy of the vaccine H56:IC31 in reducing the rate of tuberculosis disease recurrence in HIV-negative adults successfully treated for drug-susceptible pulmonary tuberculosis: a double-blind, randomised, placebo-controlled, phase 2b trial

Álvaro H. Borges, Marisa Russell, Dereck Tait et al. · The Lancet Infectious Diseases · 2025 · 18 citations

Safety and Immunogenicity of the H56:IC31 Tuberculosis Vaccine Candidate in Adults Successfully Treated for Drug-Susceptible Pulmonary Tuberculosis: A Phase 1 Randomized Trial

Dereck Tait, Andreas H. Diacon, Álvaro H. Borges et al. · The Journal of Infectious Diseases · 2024 · 10 citations